IRIS
GUCCIONE, Salvatore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.425
EU - Europa 1.908
AS - Asia 1.723
SA - Sud America 277
AF - Africa 116
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 3
Totale 8.462
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.230
SG - Singapore 858
CN - Cina 658
IE - Irlanda 515
UA - Ucraina 471
IT - Italia 354
BR - Brasile 242
CA - Canada 179
RU - Federazione Russa 144
DE - Germania 125
SE - Svezia 80
FI - Finlandia 64
SN - Senegal 48
CI - Costa d'Avorio 47
GB - Regno Unito 42
KR - Corea 42
IN - India 35
CH - Svizzera 19
UZ - Uzbekistan 19
VN - Vietnam 19
FR - Francia 16
BD - Bangladesh 14
NL - Olanda 14
AT - Austria 12
BE - Belgio 12
PL - Polonia 12
TR - Turchia 12
AR - Argentina 11
IR - Iran 11
EU - Europa 10
IQ - Iraq 10
MX - Messico 9
HK - Hong Kong 8
ZA - Sudafrica 8
IL - Israele 7
VE - Venezuela 7
PY - Paraguay 6
EC - Ecuador 5
GR - Grecia 5
JP - Giappone 5
CZ - Repubblica Ceca 4
ES - Italia 4
PK - Pakistan 4
AU - Australia 3
BG - Bulgaria 3
CO - Colombia 3
EG - Egitto 3
HN - Honduras 3
ID - Indonesia 3
LB - Libano 3
MA - Marocco 3
MD - Moldavia 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
BN - Brunei Darussalam 2
CL - Cile 2
KE - Kenya 2
NP - Nepal 2
TN - Tunisia 2
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BM - Bermuda 1
BY - Bielorussia 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
MN - Mongolia 1
MR - Mauritania 1
OM - Oman 1
RO - Romania 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 8.462
Salva come PNG Salva come JPEG
Città #
Santa Clara 656
Singapore 522
Chandler 521
Dublin 515
Jacksonville 502
Dallas 364
Chicago 266
Boardman 231
Nanjing 158
Lawrence 146
Cambridge 145
Andover 142
Toronto 136
Civitanova Marche 106
Ashburn 98
Hefei 95
Catania 90
Munich 87
San Mateo 80
Des Moines 69
Houston 69
Helsinki 58
Shenyang 55
Wilmington 53
Nanchang 49
Dakar 48
Abidjan 47
Beijing 47
Los Angeles 44
Hebei 43
Seoul 42
Saint Petersburg 40
Tianjin 30
Ottawa 27
Jiaxing 25
Changsha 22
Council Bluffs 22
São Paulo 20
Naples 15
Bremen 14
Seattle 13
Brussels 12
The Dalles 12
Augusta 11
Bari 11
Columbus 11
Moscow 11
Pune 11
Atlanta 10
Norwalk 10
Ardabil 9
Brooklyn 9
Barlassina 8
Leawood 8
Washington 8
Baghdad 7
Belo Horizonte 7
Hong Kong 7
New York 7
Zhengzhou 7
Ann Arbor 6
Dong Ket 6
Frankfurt Am Main 6
Hanoi 6
Jinan 6
Kunming 6
Liberty Lake 6
Ludwigshafen 6
Mumbai 6
Rio de Janeiro 6
Rome 6
San Francisco 6
Tashkent 6
Amsterdam 5
Asunción 5
Brasília 5
Den Haag 5
Guangzhou 5
Hangzhou 5
Ho Chi Minh City 5
Johannesburg 5
Modica 5
Ningbo 5
Phoenix 5
Syracuse 5
Tokyo 5
Warsaw 5
Agrigento 4
Ankara 4
Boston 4
Campinas 4
Charlotte 4
Chennai 4
Curitiba 4
Dhaka 4
Florianópolis 4
Montreal 4
Ragusa 4
Stockholm 4
Vancouver 4
Totale 6.088
Salva come PNG Salva come JPEG
Nome #
Application of PARM to constructing and comparing 5-HT1A and alfa1 receptor models 199
Lipophilic conjugates of methotrexate with short-chain alkylamino acids as DHFR inhibitors. Synthesis, biological evaluation, and molecular modeling 124
Pharmacological properties and biochemical mechanisms of MOR ligands might be due to different binding poses. MD Studies 97
A 3D QSAR study of Monoamino Oxidase B inhibitors, using the chemical function based pharmacophore generation approach 90
Quantum chemical and molecular dynamics studies of MUC-1 calix[4,8]arene scaffold based anti-cancer vaccine candidates 89
A new procedure for the synthesis of 4H-pyrazolo[1,5-c][1,3,5]thiadiazine-4-thiones 87
Correlating in Vitro Target-Oriented Screening and Docking: Inhibition of Matrix Metalloproteinases Activities by Flavonoids 87
4 Methyl-2-[N-(3,4-methylenedioxy-benzylidene)hydrazino]thiazole and its reduction product, 4-methyl-2-[N-(3,4-methylenedioxybenzylidene)-hydrazono]-4,5-dihydrothiazole 87
Neuroprotective effects of the monoamine oxidase inhibitor tranylcypromine and its amide derivatives against Aβ(1-42)-induced toxicity 83
5-HT1A receptors mapping by conformational analysis (2D NOESY/MM) and "tree way modelling" (HASL, CoMFA, PARM) 82
Drug delivery of synthetic antisense “Bioconjugates” for anticancer therapy DNA. 81
Spectroscopic Investigation and Molecular Modeling on Porphyrin/PAMAM Supramolecular Adduct 80
Alkylation of non-electron rich nitrogen heterocycles by alkyl orthoformates: quantum chemistry calculations 80
TCP-FA4: A derivative of tranylcypromine showing improved blood-brain permeability 80
5HT1a Receptor Binding Affinities of a Series of Serotonin Transporter (SERT) Inhibitors and Related Thermodynamic Insights 79
An efficient procedure for the synthesis of Pyrazolo[3,4-d] [1,3] Thiazin-4-ones 77
In silico screening for human norovirus antivirals reveals a novel non-nucleoside inhibitor of the viral polymerase 77
Molecular modeling and biological studies show that some μ-opioid receptor agonists might elicit analgesia acting as MMP-9 inhibitors 76
Enhancement of drug affinity for cell membranes by conjugation with lipoamino acids II. Experimental and computational evidence using biomembrane models 75
16. Towards a complete picture of chiral discrimination processes by C9 carbamate derivatives of dihydroquinine: interaction mechanisms of diastereoisomeric 9-O-[(S)- or (R)-1-(1-naphthyl)ethylcarbamate]dihydroquinine and the two enantiomers of N-(3,5-dinitrobenzoyl)alanine methyl ester 75
Enhancement of drug affinity for cell membranes by conjugation with lipoamino acids. I. Synthesis and biological evaluation of lipophilic conjugates of tranylcypromine 74
How to choose the suitable template for homology modelling of GPCRs: 5-HT7 receptor as a test case 74
3D-QSAR Using ”Multiconformer” Alignment: The Use of HASL in the Analysis of 5-HT1A Thienopyrimidinone Ligands 74
Homology-based modeling of rhodopsin-like family members in the inactive state: structural analysis and deduction of tips for modeling and optimization. 74
Application of Parm to constructing and comparing 5-HT1A and alfa1 receptor models 74
Sulfonilamidothiopyrimidone and thiopyrimidone derivatives as selective COX-2 inhibitors: Synthesis, biological evaluation, and docking studies 74
The cell cycle molecules behind neurodegeneration in Alzheimer's disease: perspectives for drug development 73
Preparation, characterisation and photosensitivity studies of solid dispersions of diflunisal and Eudragit RS100 (R) and RL100 (R) 73
DRUG DELIVERY OF SYNTHETIC ANTISENSE-DNA "BIOCONJUGATES" FOR ANTICANCER THERAPY 73
Potential of Aryl-urea-Benzofuranylthiazoles hybrids as multitasking agents in Alzheimer’s disease 72
Synthesis of new thiazinoindole derivatives and their evaluation as inhibitors of human leukocyte elastase and other related serine proteases 72
Stereoretentive Chlorination of Cyclic Alcohols Catalyzed by Titanium (IV) Tetrachloride: Evidence for a Front Side Attack Mechanism. 70
Sensory Analysis on Red Wines: Discrimination by Adaptive Fuzzy Partition (AFP) 70
Drug Delivery of Synthetic Antisense-DNA “bioconjugates” for Anticancer Therapy 70
Building a model of interaction at the NK-2 receptors: polycondensed heterocycles containing the pyrimidoindole skeleton 70
Conformational analysis and pharmacophore identification of new serotonin 5-HT4 receptor ligands made by DISCO 69
In-silico design and biological investigations of Diabetic Neuropathy modulators: could MOR become a focal mediator for this pathology? 68
An Alternative Method for 3D-QSAR and the Alignment of Molecular Structures: BiS (Biological Substrate Search) 67
Heterocyclic systems containing the pyrimido-2,4-dione ring as selective ligands for the alpha1-adrenoceptors 67
5-HT1A receptors mapping by conformational analysis (2D NOESY/MM) and ”three way modelling” (HASL, CoMFA, PARM) 67
Structural data: the basis for molecular modelling 66
Binding of imidazline ligands to the active site of purified MAO A 66
Molecular modeling studies on mu opioid receptor of agonists and antagonists, endogenous and exogenous, ligands 66
Potential of alkyl orthoformates as alkylating agents of non-electron rich nitrogen heterocycles 65
Heme Oxygenase 1 and Heme Oxygenase 2 As Druggable Targets: Docking and Two Hybrid System To Identifying and Characterizing Protein-Proten Interactions. 65
Molecular modelling and site-directed mutagenesis reveal essential residues for 5-HT7 receptor binding 65
Imidazole Derivatives as Heme Oxygenase-1 Inhibitors 65
Combining molecular modeling with experimental methodologies: mechanism of membrane permeation and accumulation of ofloxacin 65
Theoretical calculations of the catalytic triad in short chain alcohol dehydrogenases/reductases 64
Molecular modelling of a novel class of N5-methanesulfonamide dihydrothienopyrimidinoners as potential dual COX-2 inhibitor/ 64
Identification of a novel adiponectin receptor and opioid receptor dual acting agonist as a potential treatment for diabetic neuropathy 63
Pyrimido[5,4-b] Indole derivatives. 1. A new class of potent and selective alpha-1 adrenoceptor ligands 63
Synthesis and pharmacological activity of 6H-thiazolo[3’,2’:1,2]-5-oxopyrimido[5,4-b] Indole derivatives, a new heterocyclic ring system 63
Potential immunoregulatory role of heme oxygenase-1 in human milk: a combined biochemical and molecular modeling approach 62
Multi-conformational method of analysis of biological activity of molecular structures 61
Hydrophobic molecular similarity from MST fractional contributions to the octanol/water partition coefficient 60
Pyrazolothiazolopyrimidine derivatives as novel class of anti-inflammatory or antinociceptive agents: synthesis, structural characterization and pharmacological evaluation 60
Crystallographic, NMR and ab initio calculation studies of tautomerism among substituted thiazol-2-yl-hydrazines 60
Exploring the biological activity of a library of 1,2,5-oxadiazole derivatives endowed with antiproliferative activity 60
Design, synthesis and docking study of novel coumarin ligands as potential selective acetylcholinesterase inhibitors 59
Application of PARM to constructing and comparing 5-HT1A and alpha1 receptor models 59
Carbohydrate-Ligand Complex Binding: EMPIRICAL FREE ENERGY MODELING 59
ML10302 59
A field-based disparity analysis of new 1,2,5- oxadiazole derivatives endowed with antiproliferative activity 59
Interactions of imidazoline ligands with the active site of purified monoamine oxidase A 58
Synthesis and pharmacological evaluation of pyrazolopyrimidobenzoxazole and pyrazolopyrimidobenzothiazole derivatives 58
A method for determination of form and sizes of pocket in "receptor-ligand" complexes 58
DESIGN AND SYNTHESIS OF MULTIPLE LIGANS: NEW ARYLAMINES AND THEIR BINDING AFFINITY TOWARD 5-HT TRANSPORTER (SERT) AND 5-HT7- RECEPTORS 57
Sequential application of ligand and structure based modeling approaches to index chemicals for their hH4R antagonism 57
Interaction of natural flavonoid eriocitrin with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin: an NMR and molecular dynamics investigation 57
Synthesis and pharmacological evaluation of benzothieno and [1]pyridothieno [2,3-d]triazole derivatives as antagonists at NK-1 receptors 56
Study on new neurokinin antagonists: polycondensed heterocycles containing the indole skeleton 56
Building a model of interaction at the NK-2 receptors: Polycondensed heterocycles containing the pyrimidoindole skeleton 56
COMBINING NMR AND MOLECULAR MODELLING IN A DRUG DELIVERY CONTEXT: investigation of the multi-mode inclusion of a new NPY-5 antagonist bromobenzenesulfonamide into beta-cyclodextrin 56
Synthesis and pharmacological properties of pyrazolotriazolopyrimidine derivatives 55
Identification of essential residues for binding and activation in the human 5-HT7(a) serotonin receptor by molecular modeling and site-directed mutagenesis 55
MULTIGEN: A NEW PARADIGM FOR “MULTICONFORMATIONAL” ALIGNMENT OF MOLECULAR STRUCTURES IN 3D-QSAR STUDIES 55
Synthesis of 1-phenyl-6-arilsubstituted pyrazolopyrimidothiazole as antagonists at the NK-2 receptors 55
5-HT1A receptor binding analysis of thienopyrimidinones partial agonists: a paradigm breaking study regarding the pharmacophoric leadership of the protonated piperazine ring in GPCR ligands 55
Thiazole derivatives as inhibitors of purified bovine liver mitochondrial monoamine oxidase-B: structure-activity relationships and theoretical study 55
Combined NMR-crystallographic and modelling investigation of the inclusion of molsidomine into alpha-, beta - and gamma -cyclodextrins 55
Parameters for irreversible inactivation of monoamine oxidase 55
Peptidomimetics in Silico 55
Substrate and inhibitor specificity of class 1 and class 2 histone deacetylases 54
Docking simulation of complex between 2,5-xilidine and Rigidoporus lignosus laccase 54
Molecular modelling of a novel class of N5-methanesulfonamide dihydrothienopyrimidinoners as as potential dual COX-2 inhibitor/nitric oxide anti-releasing agents 53
New heterocyclic ring systems. Synthesis and pharmacological activity of 6H-1,3,4-thiadiazolo [3’,2’: 1,2]-5-oxopyrimido[5,4-b]indole derivatives and of 1-phenyl-6H-1,2,4-Triazolo [1’,5’: 1,2]-5-oxopyrimido [5,4-b]Indole 53
Potential of indole skeleton containing heterocycles as antagonists at the neurokinin (NK) receptor system 53
Receptor modeling using " Multiconformer" alignment: comparison of HASL and CoMFA in the analysis of 5-HT1A thienopyrimidinone ligands 52
Emerging antifungal azoles and effects on Magnaporthe grisea 52
Identification of an impurity in the synthesis of pharmacologically active pyrazolotriazolopyrimidines by a combined spectrometric approach 51
Comparing Log P Calculations by the Ghose-Crippen and Villar Methods 51
Potential of Pyrazolooxadiazinone Derivatives as Serine Protease Inhibitors 51
Computational Comparison of Imidazoline Association with the I2 Binding Site in Human Monoamine Oxidases 50
Molecular Modelling of endothelin ETA and ETB 50
PARM mapping of rat and human serotonin 1A (5-HT1A) receptor 50
Evaluation of Imidazole-Based Compounds as Heme Oxygenase-1 Inhibitors 50
Study of structural and dynamic behaviour of ibuprofen and its complexes with Eudragit® RL100 by means of solid state NMR 49
STUDY OF STRUCTURAL AND DYNAMIC BEHAVIOUR OF IBUPROFEN AND ITS COMPLEXES WITH EUDRAGIT® RL100 BY NERANS OF SOLID STATE 49
Synthesis and COMFA study of new heterocyclic compounds as potential AcylCoA: cholesterol O-acyltransferase inhibitors 48
Totale 6.662
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.811
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.811
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021770 0 0 131 22 243 26 80 3 73 4 148 40
2021/2022996 134 148 0 15 156 5 143 25 101 0 37 232
2022/20231.593 150 55 34 120 179 291 0 305 377 6 54 22
2023/2024517 39 68 23 39 25 81 4 12 2 16 136 72
2024/20252.721 14 472 134 157 501 351 104 132 244 270 143 199
2025/2026882 292 201 389 0 0 0 0 0 0 0 0 0
Totale 8.680